- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Pharmaids Pharmaceuticals Ltd manufactures Bulk Drugs and Intermediaries.Product Portfolio: a) Specialty Chemicals: Retinol, DL Alpha Tocopherol, D-Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10, D-Biotin b) Skin Care: Best care hands, Hands Sanitizer, Moisturizing Cream, Skin-Sure Plus, Skin-Sure Ultra, Alcohol Gel, Barrier Cream c) Hospital...
Pharmaids Pharmaceuticals has published newspaper advertisements providing e-voting information for its 37th Annual General Meeting (AGM). The AGM is scheduled for Friday, September 11, 2026, at 12 noon (IST) and will be held through video conferencing or other audio-visual means. This update informs shareholders about the upcoming key meeting and...
Pharmaids Pharmaceuticals Limited has published its unaudited financial results for the quarter ended June 30, 2026. The company advertised these financial results in the English newspaper 'Financial Express' and the vernacular newspaper 'Hosa Digantha'. Investors can also access these crucial financial updates directly on the company's website. This ensures shareholders...